Postprandial Effect of Chinese Tea Flavor Liquor on Selected CVD Risk Factors (TFL)

This study has been completed.
Sponsor:
Collaborator:
Guizhou Meijiao Co., Ltd, China
Information provided by:
Zhejiang University
ClinicalTrials.gov Identifier:
NCT01264666
First received: December 21, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted

December 21, 2010
December 21, 2010
May 2010
June 2010   (final data collection date for primary outcome measure)
serum sample [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
blood samples were collected at 0,0.5,1,2,4 hours postprandially to get serum sample.
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Postprandial Effect of Chinese Tea Flavor Liquor on Selected CVD Risk Factors
Phase I Study of Chinese Tea Flavor Liquor on Human Health

Background: human studies of Chinese liquor are sparse. we hypothesis that Chinese Tea Flavor liquor may be beneficial to CVD risk factors postprandially.

Design: three-way crossover design with one week wash time.16 young men were included to consume 60mL Chinese tea flavor liquor(45% alcohol content), Chinese Meijiao liquor 45% alcohol content) or water control.Blood samples were collected fasted, 0.5,1,2,4 hours postprandially.

Tested serum indices: lipids, glucose, insulin, hs-CRP, uric acid, liver function parameters.

Not Provided
Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Alcohols
  • Cardiovascular Diseases
  • Dietary Supplement: Chinese tea flavor liquor
    60 mL of Chinese tea flavor liquor (45% alcohol content) is consumed with high-fat meal.
  • Dietary Supplement: Chinese Meijiao liquor
  • Dietary Supplement: Water control
  • Experimental: Chinese tea flavor liquor
    Intervention: Dietary Supplement: Chinese tea flavor liquor
  • Placebo Comparator: Water
    Water combined with meal as control.
    Intervention: Dietary Supplement: Water control
  • Placebo Comparator: Chinese Meijiao Liquor
    Intervention: Dietary Supplement: Chinese Meijiao liquor
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
June 2010
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • no CVD history or liver disease, healthy young men

Exclusion Criteria:

  • smokers
Male
20 Years to 30 Years
Yes
Contact information is only displayed when the study is recruiting subjects
China
 
NCT01264666
Acute Chinese liquor study
Yes
Jusheng Zheng, Department of food science of nutrition, Zhejiang University
Zhejiang University
Guizhou Meijiao Co., Ltd, China
Not Provided
Zhejiang University
May 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP